Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT03881943
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT03881943
-
- Other papers using this trial's data
- Multi-Omics Signatures Link to Ticagrelor Effects on Vascular Function in Patients With Acute Coronary Syndrome
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03881943. Randomized; double masking; primary purpose treatment. Start 2017-01 (actual); primary completion 2018-12-21 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS
- Acronym
- FMD_ACS
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Ticagrelor 60 mg
- Intervention (Drug)
- Aspirin 100 MG Oral Tablet, Enteric Coated
- Lead sponsor
- The University of Hong Kong
Record details
- Record id
cardio:ct-nct03881943- Content hash
4d80eaae1344d12954a727ba0b359aaf6c475aed5b3b0fb2ef9776734ef97de3